DexCom (DXCM) Misses Q4 Earnings Estimates

Core Viewpoint - DexCom reported quarterly earnings of $0.45 per share, missing the Zacks Consensus Estimate of $0.50 per share, representing a -10% earnings surprise [1] - The company posted revenues of $1.11 billion for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 0.05% and showing a year-over-year increase from $1.03 billion [2] Company Performance - Over the last four quarters, DexCom has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times [2] - The stock has gained approximately 7.8% since the beginning of the year, outperforming the S&P 500's gain of 2.9% [3] Future Outlook - The company's earnings outlook is crucial for assessing future stock performance, with current consensus EPS estimates at $0.37 for the coming quarter and $2 for the current fiscal year [7] - The Zacks Rank for DexCom is currently 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Context - The Medical - Instruments industry, to which DexCom belongs, is currently in the top 34% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Another company in the same industry, Globus Medical, is expected to report quarterly earnings of $0.76 per share, reflecting a year-over-year change of +26.7% [9]